# Trial to Investigate the Effect of ESN364 in Early Postmenopausal Women Suffering From Hot Flashes

> **NCT05419908** · PHASE2 · COMPLETED · sponsor: **Ogeda S.A.** · enrollment: 87 (actual)

## Conditions studied

- Hot Flashes

## Interventions

- **DRUG:** Fezolinetant
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05419908
- **Lead sponsor:** Ogeda S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09-21
- **Primary completion:** 2016-09-21
- **Final completion:** 2016-10-06
- **Target enrollment:** 87 (ACTUAL)
- **Last updated:** 2024-11-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05419908

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05419908, "Trial to Investigate the Effect of ESN364 in Early Postmenopausal Women Suffering From Hot Flashes". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05419908. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*